Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
GlaxoSmithKline plc in Stevenage is seeking a Senior Director for Cardiovascular and Metabolic Diseases, Clinical Pharmacology Modeling and Simulation. The role will be based at Stevenage with relocation to Cambridge planned by early 2029.
You will lead Model Informed Drug Development across the lifecycle, design evidence strategies and drive regulatory-ready content while coordinating CPMS activities within RIIRU and CPQM, and building cross-functional partnerships to accelerate programs.
Senior Director, Cardiovascular and Metabolic Diseases, Clinical Pharmacology Modeling and Simulation For candidates seeking to be located at our Stevenage site, this role will temporarily be based at Stevenage. However, the Company plans to relocate its offices to Cambridge, UK. The location of this role will therefore subsequently change to Cambridge, UK in accordance with timelines to be set by the Company. The relocation is currently proposed to take effect by early 2029. The Department of Clinical Pharmacology Modelling & Simulation in Respiratory and Inflammation (CPMS R&I) at GSK is recruiting for a Director–level Clinical Pharmacologist with strong Respiratory and Inflammation expertise. This role sits within the newly established Clinical Pharmacology and Quantitative Medicine (CPQM) organisation, which aims to be a centre of excellence in Model‑Informed Drug Development (MIDD) by integrating clinical pharmacology, digital medicine, translational imaging and mechanistic/systems modelling. You will lead the end‑to‑end application of MIDD across the drug development lifecycle - from first‑in‑human studies through filing and lifecycle management - and provide clinical pharmacology strategy and evidence‑generation input. This is an opportunity to join a highly regarded, high‑impact team with a strong publication track record, reporting directly to the Respiratory, Immunology & Inflammation Research Unit (RIIRU). Main responsibilities and accountabilities include, but are not limited to:
Develop and implement robust MIDD & ClinPharm evidence strategies to de risk and accelerate RIIRU programs. Aim for faster development, optimal dosing and stronger regulatory positioning across respiratory, inflammation, neurodegeneration and emerging areas — and support business development opportunities.
Coordinate CPMS activities across and above assets within RIIRU, ensuring consistency and alignment of global CPMS/CPQM priorities and senior leadership. Work closely with CPQM peers (digital medicine, translational imaging, MIDD specialists, mechanistic/systems modelling) and cross functional partners (biology, data science, computational biology, clinical, etc.) to shape RIIRU portfolio and disease areas. Build and sustain strong working relationships inside and outside CPMS to maximise scientific and operational impact.
Approve study designs, analyses, interpretation, reports and clinical pharmacology regulatory documents across RIIRU portfolio. Draft and review clinical pharmacology regulatory content to support timely approvals and optimal labelling. Maintain up to date knowledge of FDA, EMA, CDE, PMDA and ICH expectations and embed regulatory considerations and best practices into study design and MIDD strategies. Capture and roll out lessons learned and trends to continuously improve CPMS contributions to the R&D pipeline.
Maintain strong networks and share best practices across CPQM expertise (digital medicine, QSP, translational imaging), the CPMS community of practice. Establish build strong network key functions such as AI/ML, biomarkers, biostatistics, clinical operations, data science, computational biology and RWE to embed quantitative approaches into decision making.
Raise GSK’s profile in MIDD, clinical pharmacology, QSP and AI/ML integration through publications, conference presentations and active participation in scientific and regulatory fora to influence method adoption and regulatory dialogue. Why you? Basic Qualifications: We are looking for a professional with these required skills to achieve our goals:
Preferred Qualifications:
LI-GSK* LI-Hybrid* Skills Drug Design, Drug Development, Drug Discovery Process, Drug Discovery Research, Medication Safety, Molecular Modeling, Pharmaceutical Regulatory Compliance, Pharmaceutical Sciences, Pharmacodynamics, Pharmacokinetics, Pharmacology, Pharmacometrics, Pharmacovigilance, Study Design, Target Validation
GSK is an Equal Opportunity Employer. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), parental status, national origin, age, disability, genetic information (including family medical history), military service or any basis prohibited under federal, state or local law.
Please visit GSK US Benefits Summary to learn more about the comprehensive benefits program GSK offers US employees. Why GSK? Uniting science, technology and talent to get ahead of disease together. GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale. People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.